Heart failure with preserved ejection fraction Trials in Dallas, United States
Conditions / Heart failure with preserved ejection fraction / Dallas, United States
Research into Heart failure with preserved ejection fraction spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03066804 | A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients | COMPLETED | PHASE3 |
| NCT03037580 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction | TERMINATED | PHASE3 |
| NCT02901184 | Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction | RECRUITING | PHASE3 |
| NCT03254485 | A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) | COMPLETED | PHASE2 |
| NCT01920711 | Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction | COMPLETED | PHASE3 |
| NCT05592275 | A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) | TERMINATED | PHASE2 |
| NCT06369298 | Study of JK07 in Patients With Chronic Heart Failure | RECRUITING | PHASE2 |
| NCT05723679 | Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF | RECRUITING | NA |
| NCT05064709 | Assessment of CCM in HF With Higher Ejection Fraction | RECRUITING | NA |
| NCT05139472 | Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction | COMPLETED | PHASE4 |